Literature DB >> 21961589

Organization and dynamics of Fas transmembrane domain in raft membranes and modulation by ceramide.

Bruno M Castro1, Rodrigo F M de Almeida, Erik Goormaghtigh, Aleksander Fedorov, Manuel Prieto.   

Abstract

To comprehend the molecular processes that lead to the Fas death receptor clustering in lipid rafts, a 21-mer peptide corresponding to its single transmembrane domain (TMD) was reconstituted into mammalian raft model membranes composed of an unsaturated glycerophospholipid, sphingomyelin, and cholesterol. The peptide membrane lateral organization and dynamics, and its influence on membrane properties, were studied by steady-state and time-resolved fluorescence techniques and by attenuated total reflection Fourier transformed infrared spectroscopy. Our results show that Fas TMD is preferentially localized in liquid-disordered membrane regions and undergoes a strong reorganization as the membrane composition is changed toward the liquid-ordered phase. This results from the strong hydrophobic mismatch between the length of the peptide hydrophobic stretch and the hydrophobic thickness of liquid-ordered membranes. The stability of nonclustered Fas TMD in liquid-disordered domains suggests that its sequence may have a protective function against nonligand-induced Fas clustering in lipid rafts. It has been reported that ceramide induces Fas oligomerization in lipid rafts. Here, it is shown that neither Fas TMD membrane organization nor its conformation is affected by ceramide. These results are discussed within the framework of Fas membrane signaling events.
Copyright © 2011 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21961589      PMCID: PMC3183819          DOI: 10.1016/j.bpj.2011.08.022

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  42 in total

1.  Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor.

Authors:  G Papoff; P Hausler; A Eramo; M G Pagano; G Di Leve; A Signore; G Ruberti
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

2.  The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis.

Authors:  D Scheel-Toellner; K Wang; R Singh; S Majeed; K Raza; S J Curnow; M Salmon; J M Lord
Journal:  Biochem Biophys Res Commun       Date:  2002-10-04       Impact factor: 3.575

3.  Nonequilibrium phenomena in the phase separation of a two-component lipid bilayer.

Authors:  Rodrigo F M de Almeida; Luís M S Loura; Aleksandre Fedorov; Manuel Prieto
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

4.  Ceramide-rich membrane rafts mediate CD40 clustering.

Authors:  Heike Grassmé; Verena Jendrossek; Jürgen Bock; Andrea Riehle; Erich Gulbins
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

5.  Resolution of the fluorescence excitation spectrum of indole into the 1La and 1Lb excitation bands.

Authors:  B Valeur; G Weber
Journal:  Photochem Photobiol       Date:  1977-05       Impact factor: 3.421

6.  The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells.

Authors:  C Gajate; F Mollinedo
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

7.  Molecular ordering of the initial signaling events of CD95.

Authors:  Alicia Algeciras-Schimnich; Le Shen; Bryan C Barnhart; Andrea E Murmann; Janis K Burkhardt; Marcus E Peter
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

8.  An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes.

Authors:  Anne-Odile Hueber; Anne-Marie Bernard; Zoltan Herincs; Arnaud Couzinet; Hai-Tao He
Journal:  EMBO Rep       Date:  2002-01-29       Impact factor: 8.807

9.  Structure, composition, and peptide binding properties of detergent soluble bilayers and detergent resistant rafts.

Authors:  M Gandhavadi; D Allende; A Vidal; S A Simon; T J McIntosh
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

10.  Ceramide enables fas to cap and kill.

Authors:  A Cremesti; F Paris; H Grassmé; N Holler; J Tschopp; Z Fuks; E Gulbins; R Kolesnick
Journal:  J Biol Chem       Date:  2001-04-03       Impact factor: 5.157

View more
  6 in total

1.  The mechanism of membrane disruption by cytotoxic amyloid oligomers formed by prion protein(106-126) is dependent on bilayer composition.

Authors:  Patrick Walsh; Gillian Vanderlee; Jason Yau; Jody Campeau; Valerie L Sim; Christopher M Yip; Simon Sharpe
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

2.  Keratin impact on PKCδ- and ASMase-mediated regulation of hepatocyte lipid raft size - implication for FasR-associated apoptosis.

Authors:  Stéphane Gilbert; Anne Loranger; M Bishr Omary; Normand Marceau
Journal:  J Cell Sci       Date:  2016-07-15       Impact factor: 5.285

3.  Ceramide mediates FasL-induced caspase 8 activation in colon carcinoma cells to enhance FasL-induced cytotoxicity by tumor-specific cytotoxic T lymphocytes.

Authors:  Genevieve L Coe; Priscilla S Redd; Amy V Paschall; Chunwan Lu; Lilly Gu; Houjian Cai; Thomas Albers; Iryna O Lebedyeva; Kebin Liu
Journal:  Sci Rep       Date:  2016-08-04       Impact factor: 4.379

4.  Membrane Transition Temperature Determines Cisplatin Response.

Authors:  Krishnan Raghunathan; Aarif Ahsan; Dipankar Ray; Mukesh K Nyati; Sarah L Veatch
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

5.  p53 and Ceramide as Collaborators in the Stress Response.

Authors:  Rouba Hage-Sleiman; Maria O Esmerian; Hadile Kobeissy; Ghassan Dbaibo
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

6.  Simple estimation of Förster Resonance Energy Transfer (FRET) orientation factor distribution in membranes.

Authors:  Luís M S Loura
Journal:  Int J Mol Sci       Date:  2012-11-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.